Cargando…
P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431280/ http://dx.doi.org/10.1097/01.HS9.0000971124.18635.63 |
| _version_ | 1785091163124924416 |
|---|---|
| author | Masarova, Lucia Verstovsek, Srdan Palandri, Francesca Mesa, Ruben Harrison, Claire Dobi, Balazs Gorsh, Boris Wang, Zhaohui Ellis, Catherine Patnaik, Dwaipayan Kapetanakis, Venediktos |
| author_facet | Masarova, Lucia Verstovsek, Srdan Palandri, Francesca Mesa, Ruben Harrison, Claire Dobi, Balazs Gorsh, Boris Wang, Zhaohui Ellis, Catherine Patnaik, Dwaipayan Kapetanakis, Venediktos |
| author_sort | Masarova, Lucia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431280 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104312802023-08-17 P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS Masarova, Lucia Verstovsek, Srdan Palandri, Francesca Mesa, Ruben Harrison, Claire Dobi, Balazs Gorsh, Boris Wang, Zhaohui Ellis, Catherine Patnaik, Dwaipayan Kapetanakis, Venediktos Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431280/ http://dx.doi.org/10.1097/01.HS9.0000971124.18635.63 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Masarova, Lucia Verstovsek, Srdan Palandri, Francesca Mesa, Ruben Harrison, Claire Dobi, Balazs Gorsh, Boris Wang, Zhaohui Ellis, Catherine Patnaik, Dwaipayan Kapetanakis, Venediktos P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS |
| title | P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS |
| title_full | P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS |
| title_fullStr | P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS |
| title_full_unstemmed | P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS |
| title_short | P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PACRITINIB SAFETY AND ANEMIA OUTCOMES IN PATIENTS WITH MYELOFIBROSIS |
| title_sort | p1057: indirect treatment comparisons of momelotinib vs pacritinib safety and anemia outcomes in patients with myelofibrosis |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431280/ http://dx.doi.org/10.1097/01.HS9.0000971124.18635.63 |
| work_keys_str_mv | AT masarovalucia p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT verstovseksrdan p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT palandrifrancesca p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT mesaruben p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT harrisonclaire p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT dobibalazs p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT gorshboris p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT wangzhaohui p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT elliscatherine p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT patnaikdwaipayan p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis AT kapetanakisvenediktos p1057indirecttreatmentcomparisonsofmomelotinibvspacritinibsafetyandanemiaoutcomesinpatientswithmyelofibrosis |